Kristen Mclaughlin - 13 Jan 2023 Form 4 Insider Report for Innovative Eyewear Inc (LUCY)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
06 Feb 2023, 15:06:14 UTC
Prior SEC filing
15 Aug 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Kristen Mclaughlin

Key filing fact

Kristen Mclaughlin filed Form 4 for Innovative Eyewear Inc (LUCY) on 06 Feb 2023.

Key facts

  • This page summarizes Kristen Mclaughlin's Form 4 filing for Innovative Eyewear Inc (LUCY).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 06 Feb 2023, 15:06.

Change

  • Previous filing in this sequence was filed on 15 Aug 2022.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

LUCY transaction Derivative

Option

Award

Transaction value
$0
Shares
+20,000
Change %
Price
$0.000000
Shares after
20,000
Date
13 Jan 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
20,000
Exercise price
$1.28
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents stock options granted to the reporting person on January 13, 2023, pursuant to the Issuer's 2021 Equity Incentive Plan. The stock options vest with respect to 6,667 shares on each of January 1, 2024 and January 1, 2025, and 6,666 shares on January 1, 2026.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .